Back in December, I made a post here recounting the non-profit PATH's success in developing a meningitis (MenA) vaccine, called MenAfriVac, that was sooned to be deployed in heavily stricken areas in Africa. The vaccine was developed (in part) through a $70 million dollar grant from the Bill & Melinda Gates Foundation.
PATH Meningitis Vaccine Gets $100M.
Now that the vaccine has been deployed with success in Burkina Faso, the GAVI Alliance is chipping in $100 million to see that it gets wider distribution in Cameroon, Chad, and Nigeria. As I mentioned last time, this is a feel good story of a vaccine development success through a consortia of non-profits that has real world impact on health and well-being.
Posted by Bruce Lehr May 11th 2011
Comments